154 related articles for article (PubMed ID: 34747629)
41. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
42. Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China.
Su Q; Li J; Tang Z; Yang S; Xing G; Liu T; Peng H
Med Sci Monit; 2019 Sep; 25():7138-7148. PubMed ID: 31543510
[TBL] [Abstract][Full Text] [Related]
43. ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.
Ganoci L; Trkulja V; Živković M; Božina T; Šagud M; Lovrić M; Božina N
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110042. PubMed ID: 32682874
[TBL] [Abstract][Full Text] [Related]
44. Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population.
Bosch TM; Kjellberg LM; Bouwers A; Koeleman BP; Schellens JH; Beijnen JH; Smits PH; Meijerman I
Am J Pharmacogenomics; 2005; 5(2):123-31. PubMed ID: 15813675
[TBL] [Abstract][Full Text] [Related]
45. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms of ABCG2 and its impact on clinical relevance.
Zhang W; Sun S; Zhang W; Shi Z
Biochem Biophys Res Commun; 2018 Sep; 503(2):408-413. PubMed ID: 29964015
[TBL] [Abstract][Full Text] [Related]
47. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
[TBL] [Abstract][Full Text] [Related]
48. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
49. Association and interaction between dietary patterns and gene polymorphisms in Liangshan residents with hyperuricemia.
Li T; Li S; Tian T; Nie Z; Xu W; Liu L; Jia H
Sci Rep; 2022 Jan; 12(1):1356. PubMed ID: 35079028
[TBL] [Abstract][Full Text] [Related]
50. CYP2C19
Ruedlinger J; Prado Y; Zambrano T; Saavedra N; Bobadilla B; Potthoff M; Pérez L; Lanas F; Salazar LA
Biomed Res Int; 2017; 2017():5783719. PubMed ID: 28785581
[TBL] [Abstract][Full Text] [Related]
51. Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity.
Tamura M; Kondo M; Horio M; Ando M; Saito H; Yamamoto M; Horio Y; Hasegawa Y
Nagoya J Med Sci; 2012 Feb; 74(1-2):133-40. PubMed ID: 22515119
[TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy.
Tantray JA; Reddy KP; Jamil K; Kumar YS
Int J Cardiol; 2017 Feb; 229():113-118. PubMed ID: 27915083
[TBL] [Abstract][Full Text] [Related]
53. Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance.
Kis E; Nagy T; Jani M; Molnár E; Jánossy J; Ujhellyi O; Német K; Herédi-Szabó K; Krajcsi P
Ann Rheum Dis; 2009 Jul; 68(7):1201-7. PubMed ID: 18397960
[TBL] [Abstract][Full Text] [Related]
54. Association of polymorphism of
Wang L; Zeng G; Li J; Luo J; Li H; Zhang Z
Xenobiotica; 2021 Jul; 51(7):852-858. PubMed ID: 33974505
[TBL] [Abstract][Full Text] [Related]
55. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
[TBL] [Abstract][Full Text] [Related]
56. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
Geborek P; Crnkic M; Petersson IF; Saxne T;
Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
[TBL] [Abstract][Full Text] [Related]
57. A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases.
Wang J; Sun J; Hu J; Wang C; Prinz RA; Peng D; Liu X; Xu X
FASEB J; 2020 Aug; 34(8):10132-10145. PubMed ID: 32598086
[TBL] [Abstract][Full Text] [Related]
58. Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.
Custodio A; Moreno-Rubio J; Aparicio J; Gallego-Plazas J; Yaya R; Maurel J; Higuera O; Burgos E; Ramos D; Calatrava A; Andrada E; López R; Moreno V; Madero R; Cejas P; Feliu J
Ann Oncol; 2014 Feb; 25(2):398-403. PubMed ID: 24351404
[TBL] [Abstract][Full Text] [Related]
59. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
[TBL] [Abstract][Full Text] [Related]
60. Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients.
Nakashima A; Ichida K; Ohkido I; Yokoyama K; Matsuo H; Ohashi Y; Takada T; Nakayama A; Suzuki H; Shinomiya N; Urashima M; Yokoo T
Hum Cell; 2020 Jul; 33(3):559-568. PubMed ID: 32180207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
